Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS

American Journal of Ophthalmology
Vitravene Study Group.

Abstract

To report data regarding the safety of intravitreous fomivirsen for treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). Critical review of safety data from three randomized controlled clinical trials with supplemental information from an expanded drug access program. Adverse ocular events reported by clinician investigators were listed using terms modified from the COSTART dictionary. Data for two doses (165-microg/injection [35 eyes, 30 patients] and 330-microg/injection [153 eyes, 120 patients]) and two 330-microg/injection dose schedules of different intensity were pooled to calculate incidence rates for each event. Rates were calculated as "events/patient-year" (based on total cumulative reported events and duration of treatment) for events that could recur during treatment. Rates were calculated as "patients with events/person-year" for the following events: retinal detachment, cataract, visual field disturbance, and retinal pigment epitheliopathy. To assess the ability to manage events, we reviewed treatments given for two events (anterior chamber inflammation, increased intraocular pressure) in one trial. We also report an analysis comparing the proportion of eyes that...Continue Reading

References

Jan 25, 1992·American Journal of Ophthalmology·S M WhitcupR B Nussenblatt
Sep 1, 1990·Reviews of Infectious Diseases·H H Balfour
Jul 1, 1987·Ophthalmology·D A JabsB F Polk
Sep 1, 1995·American Journal of Ophthalmology·R E Engstrom, G N Holland
Mar 6, 1998·Archives of Ophthalmology·M P KaravellasW R Freeman
Aug 26, 1998·Australian and New Zealand Journal of Ophthalmology·P J McCluskeyP Versace
Sep 29, 1999·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·H O GuembelC Ohrloff
Dec 28, 1999·Ocular Immunology and Inflammation·G N Holland
Feb 19, 2000·Current Opinion in Immunology·A M Krieg
May 3, 2000·International Ophthalmology Clinics·M ZegansR C Walton
May 12, 2000·Biochimica Et Biophysica Acta·A M Krieg
Jul 6, 2000·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C Muccioli, R Belfort

❮ Previous
Next ❯

Citations

Aug 14, 2012·EMBO Molecular Medicine·Apana A L TakwiYong Li
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Mark R UnderwoodF Leslie Boyd
Oct 31, 2012·Clinical Ophthalmology·Pedro Romero-ArocaFrancisca Bassaganyas
Mar 5, 2004·Survey of Ophthalmology·Tamara R Vrabec
Dec 2, 2004·Expert Opinion on Emerging Drugs·Arun ChakrabartyStephen K Tyring
Dec 19, 2003·Expert Opinion on Biological Therapy·P J WhiteC J Wraight
Jul 15, 2016·RNA Biology·Philipp ReautschnigThorsten Stafforst
Oct 19, 2004·Lancet·W A Lynn, S Lightman
Jan 30, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoon Shin ParkVictor C Yang
Oct 16, 2004·Retina·Lloyd P AielloMichael T Trese
Nov 11, 2006·Advanced Drug Delivery Reviews·C BloquelF Behar-Cohen
Apr 24, 2007·International Ophthalmology Clinics·Janie Ho, John I Loewenstein
Oct 20, 2004·Retina·Rama D JagerEmmett T Cunningham
Nov 19, 2005·Expert Review of Medical Devices·Margaret Chang, James P Dunn
Aug 4, 2005·Retina·Daniel E GoldbergWilliam R Freeman
Mar 27, 2010·Arquivos de neuro-psiquiatria·Ricardo André Amorim LeiteMaria de Fátima Vasco Aragão
Mar 16, 2017·EMBO Molecular Medicine·Caroline GodfreyVirginia Arechavala-Gomeza
Sep 4, 2019·Journal of Cellular Biochemistry·Muhammad Imran QadirMajid Manzoor
Dec 11, 2007·Nature Biotechnology·Joost HaasnootBen Berkhout
Oct 15, 2019·Frontiers in Genetics·Alireza ShahryariHeiko Lickert
Dec 2, 2004·Dermatologic Therapy·Arun Chakrabarty, Karl Beutner
Mar 26, 2021·Nature Reviews. Drug Discovery·Stanley T CrookeXue-Hai Liang
May 20, 2021·Seminars in Ophthalmology·Kevin FerenchakRachel Huckfeldt
Nov 3, 2004·Toxicology and Applied Pharmacology·Tracey L H JasonRandal W Berg
Dec 24, 2004·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Scott P HenryArthur A Levin
Apr 20, 2005·Dermatologic Clinics·Jashin J WuStephen K Tyring
Jan 13, 2018·Chemical Reviews·Alicia J AngelbelloMatthew D Disney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.